Crucell's Exchange Offer for Berna Biotech successful
The Board of Berna Biotech AG announced that until the end of the regular offer period a large majority of the shareholders of Berna has followed its recommendation and accepted the Public Exchange Offer by Crucell N.V. for all outstanding Berna shares. On January 20, 2005, at 16.00 hours CET, 27,804,193 Berna shares had been tendered in accordance with the offer which represents 73.9% of the issued Berna shares at that date.
Subject to certain conditions subsequent as set forth in the offer prospectus and in the official publication of the interim result, Crucell has therefore declared the Exchange Offer as successful.
As described in the Exchange Offer document, Berna shareholders will receive 0.447 Crucell shares per Berna share tendered and delivered. Barring unforeseen circumstances, Berna shareholders will receive their new Crucell shares on Wednesday February 22, 2006, when the shares of Crucell N.V. are also expected to be listed on the main segment of SWX in Zürich.
Berna shareholders who have not yet tendered their Berna shares have the opportunity to tender and deliver their shares, under the same terms as those stated in the Exchange Offer, during the additional acceptance period, which will last from January 26, 2006, until Wednesday February 8, 2006, 16.00 hours CET.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.
